| |
|
View this email in your browser
|
|
| |
CORONA, CA–(Marketwired – November 02, 2015) – Acology Inc. (OTC PINK: ACOL)This bale of hay nearly devastated a ranch.
Chase Sponsor
Dear Acology Shareholders:
Since my last letter to you on October 7 there have been several positive developments that I want to share with you.
One year ago, in October 2014, Acology had contracted and sold its products to less than 45 North American distributors. By the end of 2015 Acology will have acquired, contracted and sold products to more than 900 domestic and international distributors, wholesalers, merchants and brokers. This impressive achievement has succeeded in increasing sales for each calendar month of 2015. These results, along with the continuing execution of both new and ongoing marketing efforts, promise steady growth for calendar 2016. Reorders have continued to advance due to very aggressive sales and marketing and a strong social media campaign. October will set another record for the largest gross-sales receipts in the company's history.
Acology is advancing on the medical-device front as well. After welcoming Dr. Vincent Nguyen, DO.,CMD and Program Director of Hoag Hospital's CARES Palliative Care Program and colleges Josh Luke, PHD, Director of the National Re-Admission Coalition Cooperative and Michael Demoratz, PHD, Administrator of 24/7 Care to Acology's Advisory Board, we gathered in formal session on the 27th of October for the purpose of beginning the collaboration needed to make a strong entrance into the hospice, palliative and cognitive care industries with our signature product, The MedTainer™. Affording Acology executives their rare insight and expertise in these fields these three distinguished men have begun guiding Acology to contacts in the medical device and patient care industry, including large corporate entities centered in Southern California. The MedTainer is now in clinical trials with several large, nation-wide patient care providers who have been supplied with Acology's patented product and are using MedTainers to improve their patient's medication control. In the short time that the trials have run the feedback from clinicians and care givers has been very positive. Acology's intention is to fully capitalize these successful clinical outcomes and create substantial MedTainer sales in these markets.
Responding to the need to increase the capabilities and capacity of our business operations Acology's expansion and building of the new 5,000 sq.ft. extension continues and the intention is to be fully operational by the close of 2015.
Thank you for your continued support.
Sincerely,
Curt Fairbrother, CEO
Acology Inc. / D&C Distributors, LLC
Safe Harbor Statement
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's email is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).
Disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: InvestorNewsSource.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
InvestorNewsSource.com is often times compensated to feature certain companies. These third parties may have shares and may liquidate the company's shares which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. InvestorNewsSource.com, and/or members of the company (Investor News Source) may also be compensated often times in free trading or restricted stock by a third party non-affiliate to represent a specific company. Investor News Source intent is to sell those shares immediately. Investor News Source may, from time to time, purchase shares of public companies that we have been compensated to feature or profile in the open market and Investor News Source does this at fair market value.
Release of Liability: Through use of this website viewing or using you agree to hold InvestorNewsSource.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. InvestorNewsSource.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and InvestorNewsSource.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead InvestorNewsSource.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. InvestorNewsSource.com is compliant with the Can Spam Act of 2003. InvestorNewsSource.com does not offer such advice or analysis, and InvestorNewsSource.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, InvestorNewsSource.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, InvestorNewsSource.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. InvestorNewsSource.com is not responsible for any claims made by the companies advertised herein, nor is InvestorNewsSource.com responsible for any other promotional firm, its program or its structure.
Third Party Web Sites and InformationInvestorNewsSource.com and newsletter may provide hyperlinks to third party websites or access to third party content. InvestorNewsSource.com does not control, endorse, or guarantee content found in such sites. You agree that InvestorNewsSource.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that InvestorNewsSource.com, Inc. shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. For Full Compensation Disclosure go to investornewssource.com/disclaimer. Inveswtor News Source has been compensated $19,500 for coverage on ACOL by TOby Smith a 3rd party Shareholder that has free trading shares and may sell at anytime and could negativly effect the stock price.
|
|
|
| |
|
Unsubscribe me from all of your future newsletter.
|
|
| |
|
